Published in Surg Today on May 31, 2008
All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev (2012) 1.74
Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc (2011) 1.35
Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides (2009) 1.19
Eating behavior in rats subjected to vagotomy, sleeve gastrectomy, and duodenal switch. J Gastrointest Surg (2010) 0.79
Utilization of hospital services by obese patients before and after bariatric surgery. Surg Today (2013) 0.77
Treatment of diabetes prior to and after bariatric surgery. J Diabetes Sci Technol (2012) 0.75
Effects of duodeno-jejunal bypass on glucose metabolism in obese rats with type 2 diabetes. Surg Today (2013) 0.75
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab (2001) 3.16
Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg (2005) 2.91
Recommendations for reporting weight loss. Obes Surg (2003) 2.40
Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg (2003) 2.14
Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice? Surg Today (2007) 1.71
Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg (2005) 1.61
Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg (2006) 1.49
Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes (2003) 1.49
Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg (2004) 1.31
Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg (2005) 1.28
Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50). Obes Surg (2005) 1.25
Biliopancreatic Diversion with a New Type of Gastrectomy. Obes Surg (1993) 1.19
Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg (2006) 1.16
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol (2002) 1.08
Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes (2002) 0.98
Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol (Oxf) (2002) 0.92
Feasibility of laparoscopic sleeve gastrectomy as a revision procedure for prior laparoscopic gastric banding. Obes Surg (2006) 0.91
The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg (2004) 0.90
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab (2002) 0.88
Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass. Obes Surg (2005) 0.85
The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review. Dig Dis Sci (2007) 0.84
Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg (2004) 0.78
Laparoscopic adjustable gastric banding with duodenal switch for morbid obesity: technique and preliminary results. Obes Surg (2003) 0.76
Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci (2008) 2.26
Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer (2004) 1.70
Value of routine postoperative gastrographin contrast swallow studies after laparoscopic gastric banding. Arch Surg (2009) 1.43
Complications after sleeve gastrectomy for morbid obesity. Obes Surg (2008) 1.37
Cell types obtained from the epidural space of patients with low back pain/radiculopathy. Pain Pract (2009) 1.37
Reinforcement does not necessarily reduce the rate of staple line leaks after sleeve gastrectomy. A review of the literature and clinical experiences. Obes Surg (2008) 1.36
Nanotechnology and human health: risks and benefits. J Appl Toxicol (2010) 1.15
AKAP-4: a novel cancer testis antigen for multiple myeloma. Br J Haematol (2008) 1.11
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer. Int Rev Immunol (2011) 1.06
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med (2007) 1.05
Morbid obesity causes chronic increase of intraabdominal pressure. Dig Dis Sci (2007) 1.03
Cancer: looking for simplicity and finding complexity. Cancer Cell Int (2006) 1.01
Comparison of standard polyvinyl chloride tracheal tubes and straight reinforced tracheal tubes for tracheal intubation through different sizes of the Airtraq laryngoscope in anesthetized and paralyzed patients: a randomized prospective study. Anesthesiology (2009) 1.00
Hepatoid carcinoma of the pancreas: a case report. Chin Med J (Engl) (2007) 0.98
Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood (2002) 0.98
Sperm protein 17 is expressed in human somatic ciliated epithelia. J Histochem Cytochem (2004) 0.96
The complexity of anatomical systems. Theor Biol Med Model (2005) 0.96
Sperm protein 17 is expressed in human nervous system tumours. BMC Cancer (2006) 0.93
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia. J Pathol (2011) 0.93
Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer (2005) 0.92
A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Immunol Rev (2008) 0.92
PSA screening and deaths from prostate cancer after diagnosis--a population based analysis. Prostate (2013) 0.92
Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage? Expert Opin Biol Ther (2011) 0.90
Retracted Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels. J Drug Target (2005) 0.90
Infection, replication, and cytopathology of human papillomavirus type 31 in trophoblasts. Virology (2003) 0.89
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol (2006) 0.89
Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action. Int J Cancer (2005) 0.89
Geometry of human vascular system: is it an obstacle for quantifying antiangiogenic therapies? Appl Immunohistochem Mol Morphol (2007) 0.89
Countries with high circumcision prevalence have lower prostate cancer mortality. Asian J Androl (2015) 0.88
Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol (2008) 0.88
Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J Immunol Methods (2006) 0.87
Immunolocalization of sperm protein 17 in human testis and ejaculated spermatozoa. J Histochem Cytochem (2003) 0.87
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma. PLoS One (2011) 0.86
COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats. J Surg Res (2009) 0.86
The impact of morbid obesity on the state economy: an initial evaluation. Surg Obes Relat Dis (2006) 0.85
Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer. Drug Dev Res (2006) 0.85
Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling. Clin Exp Metastasis (2007) 0.85
Notch-ing from T-cell to B-cell lymphoid malignancies. Cancer Lett (2011) 0.85
Biological treatment for liver tumor and new potential biomarkers. Dig Dis Sci (2007) 0.85
Crural repair permits morbidly obese patients with not large hiatal hernia to choose laparoscopic adjustable banding as a bariatric surgical treatment. Obes Surg (2008) 0.85
Is sperm protein 17 a useful target for tumor immunotherapy? Blood (2003) 0.84
The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review. Dig Dis Sci (2007) 0.84
Cancer initiation and progression: an unsimplifiable complexity. Theor Biol Med Model (2006) 0.84
Cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability. Int Rev Immunol (2012) 0.84
A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery. Obesity (Silver Spring) (2006) 0.83
Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells. Anticancer Res (2008) 0.83
Bariatric surgery costs and implications for hospital margins: comparing laparoscopic gastric bypass and laparoscopic gastric banding. Surg Laparosc Endosc Percutan Tech (2007) 0.83
Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy. Int Rev Immunol (2015) 0.83
A cost-benefit analysis of bariatric surgery on the South Plains region of Texas. Obes Surg (2011) 0.83
Mast cells and human hepatocellular carcinoma. World J Gastroenterol (2003) 0.83
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4. BMC Cancer (2011) 0.83
Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen. Cancer Immunol Immunother (2013) 0.83
Heparin and carboxymethylchitosan metal nanoparticles: an evaluation of their cytotoxicity. Biomed Res Int (2013) 0.83
Sperm protein 17 expression defines 2 subsets of primary esthesioneuroblastoma. Hum Pathol (2005) 0.82
Endoscopic suture removal at gastrojejunal anastomosis after Roux-en-Y gastric bypass to prevent marginal ulceration. Surg Obes Relat Dis (2007) 0.82
Application of vitamin D and derivatives in hematological malignancies. Cancer Lett (2011) 0.82
Laparoscopic sleeve gastrectomy with endoscopic guidance in morbid obesity. Surg Obes Relat Dis (2008) 0.82
Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction. Tissue Eng (2005) 0.81
Is surgery the next answer to treat obesity-related hypertension? J Clin Hypertens (Greenwich) (2009) 0.81
Endoscopic thyroidectomy: the development in a Chinese center. J Laparoendosc Adv Surg Tech A (2011) 0.81
Defining tumor antigens: mRNA, protein or cytotoxicity? Trends Immunol (2002) 0.81
ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro. Kidney Int (2005) 0.81
Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells. Cancer Gene Ther (2005) 0.81
Expression profiling of genes involved in collagen turnover in tendons from cerebral palsy patients. Connect Tissue Res (2009) 0.81
Glioma-astrocyte interaction modifies the astrocyte phenotype in a co-culture experimental model. Oncol Rep (2009) 0.81
The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol (2014) 0.81
The adeno-associated virus major regulatory protein Rep78-c-Jun-DNA motif complex modulates AP-1 activity. Virology (2003) 0.80
Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation. J Pharm Pharmacol (2006) 0.80
rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer. Viral Immunol (2008) 0.80
A proposed canine model of laparoscopic nonanatomic liver resection. J Laparoendosc Adv Surg Tech A (2006) 0.80
Ukrain affects pancreas cancer cell phenotype in vitro by targeting MMP-9 and intra-/extracellular SPARC expression. Pancreatology (2010) 0.79
Complexity and cancer. Gastroenterology (2004) 0.79
The role of radiofrequency ablation in multiple liver metastases to debulk the tumor: a pilot study before alternative therapies. J Laparoendosc Adv Surg Tech A (2007) 0.79
Temporal acceleration of the human papillomavirus life cycle by adeno-associated virus (AAV) type 2 superinfection in natural host tissue. Virology (2002) 0.79
The economic impact of morbid obesity. Surg Endosc (2009) 0.79
Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race. BMC Cancer (2006) 0.78
Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications. Int Rev Immunol (2015) 0.78
Laparoscopic gastric bypass for morbid obesity decreases bodily pain, improves physical functioning, and mental and general health in women. J Laparoendosc Adv Surg Tech A (2007) 0.78
Pancreas cancer survival in the gemcitabine era. Clin Med Oncol (2008) 0.78
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity. Cancer Immunol Immunother (2004) 0.78
Outcomes for patients who develop both breast and colorectal cancer. Ann Surg Oncol (2011) 0.78
Evaluation of an intraoperative algorithm based on near-infrared refracted spectroscopy monitoring, in the intraoperative decision for shunt placement, in patients undergoing carotid endarterectomy. Middle East J Anaesthesiol (2011) 0.78
Laparoscopic sleeve gastrectomy after gastric banding removal: a feasibility study. Surg Innov (2008) 0.78
Hepatocyte infusions improve the results of liver transplantation in rats. Hepatogastroenterology (2010) 0.77
Retracted Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin. J Drug Target (2006) 0.77
Pituitary tumor transforming gene 1 in the liver. Hepatology (2006) 0.77
Lymphoepithelial cyst of the pancreas tail. Case report and review of the literature. JOP (2008) 0.77
Mast cell density: a quantitative index of acute liver inflammation. Anal Quant Cytol Histol (2002) 0.77
Laparoscopic splenectomy: a 12-year single-center experience. Chin Med J (Engl) (2008) 0.77
Outcomes for patients who are diagnosed with breast and endometrial cancer. Oncol Lett (2013) 0.77
Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium. Int Rev Immunol (2015) 0.77
Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer? Int Rev Immunol (2014) 0.77
Discordance between cytologic results in multiple thyroid nodules within the same patient. Acta Cytol (2010) 0.77
Perspective for prophylaxis and treatment of cervical cancer: an immunological approach. Int Rev Immunol (2012) 0.77
AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet. J Transl Med (2014) 0.77
Retracted Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Minim Invasive Ther Allied Technol (2008) 0.77
Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection. Curr Cancer Drug Targets (2015) 0.76